Skip to main content

Universities announce rare disease research agreement with Pfizer Inc.

Today, GMEC, the Global Medical Excellence Cluster, announced a five year collaborative agreement with Pfizer Inc. that provides a framework for the research and development of new and innovative medicines for rare diseases.

Published on:

For media information, contact:

Back to top